All lobbying filings

COMMUNITY ONCOLOGY ALLIANCE

COMMUNITY ONCOLOGY ALLIANCE filed a Q3 report for COMMUNITY ONCOLOGY ALLIANCE on October 16, 2025.

Lobbying for COMMUNITY ONCOLOGY ALLIANCE

All filings by COMMUNITY ONCOLOGY ALLIANCE · Everything COMMUNITY ONCOLOGY ALLIANCE has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Expenses

$221,500

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Enhancing Oncology Model issues/problems (CMS/CMMI)

Bills named in this filing 2

H.R. 2484
Seniors’ Access to Critical Medications Act of 2025
H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.